edgen-logo

AI Copilot
portfolioPortfolio

Stocks

Crypto

News
StocksCrypto

Chat History

Aura
Follow our

Join our

EN
Back

Monte Rosa Therapeutics Shares Advance on Expanded Novartis Collaboration
Stock NewsThemesMonte Rosa Therapeutics Shares Advance on Expanded Novartis Collaboration

Monte Rosa Therapeutics Shares Advance on Expanded Novartis Collaboration

Edgen StockEdgen Stock·Sep 16 2025, 22:52
Share to
Share to
Copy link
NVSNVS+1.39%
Monte Rosa Therapeutics Shares Advance on Expanded Novartis Collaboration
source:
[1] Monte Rosa Therapeutics And The Promise Of Molecular Glue Degraders (https://seekingalpha.com/article/4823309-mont ...)[2] Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases - Investing News Network (https://vertexaisearch.cloud.google.com/groun ...)[3] Monte Rosa Therapeutics Shares Soar on Drug Partnership with Novartis - Morningstar (https://vertexaisearch.cloud.google.com/groun ...)

Related News

Babcock & Wilcox Secures $40M Refinery Contract
Dec 19 2025, 22:38

Babcock & Wilcox Secures $40M Refinery Contract

Babcock & Wilcox announced on December 19, 2025, that it secured a $40 million contract to supply its Wet Gas Scrubbing technology to a Canadian petroleum refinery, major Canadian petroleum refinery.

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales
Dec 19 2025, 22:29

Tesla Profits Plunge 53% as Politics Cost 1.26M Sales

A Yale study finds Elon Musk's political stance cost Tesla 1.26 million car sales, contributing to a profit drop to $7.1 billion in 2024 from $15 billion in 2023.

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes
Dec 19 2025, 22:27

Mizuho Lifts Tesla Target to $530 on Robotaxi Hopes

On December 16, Mizuho increased its price target for Tesla to $530, citing growing confidence in the automaker's future robotaxi business.